Clinical Trials
> Head and Neck Cancer > B9991016
 
B9991016 A Randomized Double-Blind Phase 3 Study of Avelumab in Combination with Standard of Care Chemo-radiotherapy (Cisplatin Plus Definitive Radiation Therapy) Versus Standard of Care Chemo-radiotherapy In the Front-Line Neck Treatment of Patients with Locally Advanced Squamous Cell Carcinoma of the Head and Neck.
   
1. WHAT TYPE OF CANCER? WHAT STAGE?
Head and Neck Cancer.
 
2. WHO IS ELIGIBLE?
First line treatment.
 
3. HOW WILL I BE TREATED?
All patients get definitive treatment. Patients may also get Avelumab (immunotherapy).

Send an Inquiry

  • -
  • Reload
  • Should be Empty:

Disclaimer: This website is only for the purpose of sending an inquiry about a clinical trial. Your contact information will be passed our clinical trial coordinators who will pass on your contact information to the physician’s office that is sponsoring the trial that you are interested in. Entry into any clinical trial is not guaranteed – reasons for this include but are not limited to the fact that you may not be eligible, the trial may be completed or closed, or the possible treatments may not be indicated or appropriate for you.

We will attempt to contact you via your inquiry within (5) five business days, however, we cannot guarantee that you will be contacted. Though we update this website several times a year, there may be clinical trials that are not on this list or trials on this list may have closed.

This website does not is not designed to give medical advice, and does not take the place of your physician. If you have an urgent medical matter, please contact your physician or call emergency medical services.

(c) Sidd Padmanabha, M.D., and Jefferson Radiation Oncology, 2018.